Close

Novartis begins shipment of Fluvirin influenza seasonal vaccine in US

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US.

Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new influenza strains. The reformulation meets the updated World Health Organization and US Food and Drug Administration (FDA) recommendations.

Novartis North America regional head and US Vaccines president Brent MacGregor said the company is ensuring adequate supply of Fluvirin to meet the customer demand. “The influenza vaccine will arrive in time to help meet a significant public health need and allow healthcare professionals to start administering vaccines in the lead up to the influenza season,” MacGregor added.

Fluvirin vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons four years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. Seasonal influenza is a highly communicable, acute viral infection that predominantly attacks the respiratory tract and sometimes the lungs. It can cause mild to severe illness and can also lead to death.

 

Latest stories